Skip to main content

Table 9 Clinicopathological characteristics of 78 PDAC patients

From: Candidate microRNA biomarkers of pancreatic ductal adenocarcinoma: meta-analysis, experimental validation and clinical significance

Gender

 

Male

44 (56%)

Female

34 (44%)

T category

 

T1

14 (18%)

T2

26 (33%)

T3

28 (36%)

T4

10 (13%)

N category

 

NO

34 (44%)

N1

44 (56%)

M category

 

M0

70 (90%)

M1

8 (10%)

Tumour size

 

≥2 cm

42 (54%)

<2 cm

36 (46%)

Histology

 

Well or moderately differentiated

38 (49%)

Poorly differentiated

40 (51%)

Perineural invasion

 

None or slight

46 (59%)

Prominent

32 (41%)

Venous invasion

 

None or slight

40 (51%)

Prominent

38 (49%)

Tumour grade (UICC)

 

Stage I-IIA

32 (41%)

Stage IIB-IV

46 (59%)

Resection margin status

 

R0

32 (41%)

R1

46 (59%)